Skip to main content
PMC home page
Gut logoLink to Gut
. 1996;38(Suppl 2):S5–12. doi: 10.1136/gut.38.suppl_2.s5

The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa.

C F Kiire 1
PMCID: PMC1398049  PMID: 8786055

Abstract

There are approximately 50 million chronic carriers of hepatitis B virus (HBV) in Africa, with a 25% mortality risk. In sub-Saharan Africa, carrier rates range from 9-20%. Many studies have suggested that HBV transmission in Africa occurs predominantly in childhood, by the horizontal rather than the perinatal route. The exact mode of transmission is uncertain but probably involves percutaneous infection through saliva or traces of blood, as well through unsterile needles, tribal scarification, and other possible vehicles. Compared with adult HBsAg carriers in the Far East, those in Africa have a low rate of HBeAg positivity, which may account for the relatively low rates of perinatal infection. It is also possible that African infants are less susceptible to perinatal HBV infection compared with their Asian counterparts. Alternatively, it may be that African infants are indeed infected with HBV at birth but, for genetically determined reasons, have persistently negative tests for a number of years until the virus is reactivated. In view of the high HBV carrier rates in the general population, universal immunisation of all infants is recommended. Ways of incorporating the hepatitis B vaccine into the Expanded Programme on Immunisation in each country are being evaluated.

Full text

PDF
S5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoola E. A., Atoba M. A., Johnson A. O. Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results. Arch Virol. 1986;91(3-4):291–296. doi: 10.1007/BF01314288. [DOI] [PubMed] [Google Scholar]
  2. Bagshawe A., Nganda T. N. Hepatitis B antigen in a rural community in Kenya. Trans R Soc Trop Med Hyg. 1973;67(5):663–670. doi: 10.1016/0035-9203(73)90036-9. [DOI] [PubMed] [Google Scholar]
  3. Barin F., Goudeau A., Denis F., Yvonnet B., Chiron J. P., Coursaget P., Mar I. D. Immune response in neonates to hepatitis B vaccine. Lancet. 1982 Jan 30;1(8266):251–253. doi: 10.1016/s0140-6736(82)90977-1. [DOI] [PubMed] [Google Scholar]
  4. Barin F., Perrin J., Chotard J., Denis F., N'Doye R., Diop Mar I., Chiron J. P., Coursaget P., Goudeau A., Maupas P. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol. 1981;27:148–162. [PubMed] [Google Scholar]
  5. Barin F., Yvonnet B., Goudeau A., Coursaget P., Chiron J. P., Denis F., Mar I. D. Hepatitis B vaccine: further studies in children with previously acquired hepatitis B surface antigenemia. Infect Immun. 1983 Jul;41(1):83–87. doi: 10.1128/iai.41.1.83-87.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Basalamah A. H., Serebour F., Kazim E. Materno-foetal transmission of hepatitis B in Saudi Arabia. J Infect. 1984 May;8(3):200–204. doi: 10.1016/s0163-4453(84)93835-0. [DOI] [PubMed] [Google Scholar]
  7. Beasley R. P., Hwang L. Y., Stevens C. E., Lin C. C., Hsieh F. J., Wang K. Y., Sun T. S., Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 1983 Mar-Apr;3(2):135–141. doi: 10.1002/hep.1840030201. [DOI] [PubMed] [Google Scholar]
  8. Botha J. F., Ritchie M. J., Dusheiko G. M., Mouton H. W., Kew M. C. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet. 1984 Jun 2;1(8388):1210–1212. doi: 10.1016/s0140-6736(84)91694-5. [DOI] [PubMed] [Google Scholar]
  9. Bowry T. R. The pattern of transmission of hepatitis B virus in an urban population of Kenya. East Afr Med J. 1984 May;61(5):385–392. [PubMed] [Google Scholar]
  10. Cancio-Bello T. P., de Medina M., Shorey J., Valledor M. D., Schiff E. R. An institutional outbreak of hepatitis B related to a human biting carrier. J Infect Dis. 1982 Nov;146(5):652–656. doi: 10.1093/infdis/146.5.652. [DOI] [PubMed] [Google Scholar]
  11. Chiron J. P., Coursaget P., Yvonnet B., Auger F., Lee Quan T., Barin F., Denis F., Diop-Mar I. Simultaneous administration of hepatitis B and diphtheria/tetanus/polio vaccines. Lancet. 1984 Mar 17;1(8377):623–624. doi: 10.1016/s0140-6736(84)91015-8. [DOI] [PubMed] [Google Scholar]
  12. Coursaget P., Yvonnet B., Chotard J., Sarr M., Vincelot P., N'doye R., Diop-Mar I., Chiron J. P. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet. 1986 Nov 15;2(8516):1143–1145. doi: 10.1016/s0140-6736(86)90543-x. [DOI] [PubMed] [Google Scholar]
  13. Coursaget P., Yvonnet B., Chotard J., Vincelot P., Sarr M., Diouf C., Chiron J. P., Diop-Mar I. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol. 1987 May;22(1):1–5. doi: 10.1002/jmv.1890220102. [DOI] [PubMed] [Google Scholar]
  14. Dibisceglie A. M., Kew M. C., Dusheiko G. M., Berger E. L., Song E., Paterson A. C., Hodkinson H. J. Prevalence of hepatitis B virus infection among black children in Soweto. Br Med J (Clin Res Ed) 1986 May 31;292(6533):1440–1442. doi: 10.1136/bmj.292.6533.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ghendon Y. Perinatal transmission of hepatitis B virus in high-incidence countries. J Virol Methods. 1987 Aug;17(1-2):69–79. doi: 10.1016/0166-0934(87)90070-x. [DOI] [PubMed] [Google Scholar]
  16. Hyams K. C., Okoth F. A., Tukei P. M., Mugambi M., Johnson B., Morrill J. C., Gray G. C., Woody J. N. Epidemiology of hepatitis B in eastern Kenya. J Med Virol. 1989 Jun;28(2):106–109. doi: 10.1002/jmv.1890280210. [DOI] [PubMed] [Google Scholar]
  17. Korba B. E., Wells F., Tennant B. C., Yoakum G. H., Purcell R. H., Gerin J. L. Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis. J Virol. 1986 Apr;58(1):1–8. doi: 10.1128/jvi.58.1.1-8.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prozesky O. W., Stevens C. E., Szmuness W., Rolka H., Harley E. J., Kew M. C., Scholtz J. E., Mitchell A. D. Immune response to hepatitis B vaccine in newborns. J Infect. 1983 Jul;7 (Suppl 1):53–55. doi: 10.1016/s0163-4453(83)96649-5. [DOI] [PubMed] [Google Scholar]
  19. Prozesky O. W., Szmuness W., Stevens C. E., Kew M. C., Harley E. J., Hoyland J. A., Scholtz J. E., Mitchell A. D., Shabangu A., Kunene E. Baseline epidemiological studies for a hepatitis B vaccine trial in Kangwane. S Afr Med J. 1983 Nov 26;64(23):891–893. [PubMed] [Google Scholar]
  20. Tabor E., Bayley A. C., Cairns J., Pelleu L., Gerety R. J. Horizontal transmission of hepatitis B virus among children and adults in five rural villages in Zambia. J Med Virol. 1985 Feb;15(2):113–120. doi: 10.1002/jmv.1890150203. [DOI] [PubMed] [Google Scholar]
  21. Tsega E., Mengesha B., Hansson B. G., Lindberg J., Nordenfelt E. Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data. Am J Epidemiol. 1986 Feb;123(2):344–351. doi: 10.1093/oxfordjournals.aje.a114243. [DOI] [PubMed] [Google Scholar]
  22. Tsega E., Mengesha B., Nordenfelt E., Hansson B. G., Lindberg J. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary? Trop Geogr Med. 1987 Oct;39(4):336–340. [PubMed] [Google Scholar]
  23. Tsega E., Tsega M., Mengesha B., Nordenfelt E., Hansson B. G., Lindberg J. Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol. 1988 Dec;17(4):874–879. doi: 10.1093/ije/17.4.874. [DOI] [PubMed] [Google Scholar]
  24. Whittle H. C., Bradley A. K., McLauchlan K., Ajdukiewicz A. B., Howard C. R., Zuckerman A. J., McGregor I. A. Hepatitis B virus infection in two Gambian villages. Lancet. 1983 May 28;1(8335):1203–1206. doi: 10.1016/s0140-6736(83)92477-7. [DOI] [PubMed] [Google Scholar]
  25. Yvonnet B., Coursaget P., Chotard J., Sarr M., NDoye R., Chiron J. P., Diop-Mar I. Hepatitis B vaccine in infants from an endemic area: long-term anti-HBs persistence and revaccination. J Med Virol. 1987 Aug;22(4):315–321. doi: 10.1002/jmv.1890220404. [DOI] [PubMed] [Google Scholar]
  26. Yvonnet B., Coursaget P., Deubel V., Diop-Mar I., Digoutte J. P., Chiron J. P. Simultaneous administration of hepatitis B and yellow fever vaccines. Dev Biol Stand. 1986;65:205–207. [PubMed] [Google Scholar]
  27. Yvonnet B., Coursaget P., Petat E., Tortey E., Diouf C., Barin F., Denis F., Diop-Mar I., Chiron J. P. Immunogenic effect of hepatitis B vaccine in children: comparison of two- and three-dose protocols. J Med Virol. 1984;14(2):137–139. doi: 10.1002/jmv.1890140207. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES